drugset / Trial / NCT07289750
The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD
Phase 4
Not yet recruiting
80 enrolled
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy and safety of the combination of alogliptin and actoplus met with that of actoplus met alone in improving the glucose and lipid metabolism and pancreatic function in T2DM patients complicated with MAFLD.
Timeline
- Start
- 2026-05-01
- Primary completion
- 2027-08-31
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alogliptin | Unknown | — | — |
| Comparator | Metformin | Small molecule | — | — |
| Comparator | Pioglitazone | Small molecule | — | — |